Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Integrated CBT and Buprenorphine for Chronic Pain and Opioid Dependence (POD)
NCT00634803Phase 2Completed
- Sponsor
- Yale University
- Start
- Sep 2009
- Primary completion
- May 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of buprenorphine in opioid use disorder (OUD), chronic pain, sponsored by Yale University. Started Sep 2009; status: completed.
02
Drugs
buprenorphine
03
Conditions
opioid use disorder (OUD)chronic pain
Beyond the preview
Go deeper on NCT00634803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00634803.